not losing weight with semaglutide Why is my GLP-1 medication working? Women's Nutritional Support for Size:240 CT Product Type_Capsules

not losing weight with semaglutide Why is my GLP-1 medication working? Women's Nutritional Support for Size:240 CT Product Type_Capsules

Women's Nutritional Support for GLP-1 Users

Key Takeaways Retatrutide targets three hormones (GLP-1, GIP, glucagon), tirzepatide targets two (GLP-1, GIP), and semaglutide targets one (GLP-1) At 68 weeks, retatrutide achieved 28.7% average weight loss, tirzepatide approximately 22%, and semaglutide around 17% on the highest doses Side effects are similar across all three medications, mainly digestive issues like nausea and diarrhoea Retatrutide is not yet approved and won't be available until mid-2026 at the earliest Retatrutide is not yet approved and is not currently available in the UK Tirzepatide (Mounjaro) and semaglutide (Wegovy) are both available now in the UK through NHS or private providers By entering I agree to the Terms and Conditions

Product Type_Capsules

Size:240 CT

Does Retatrutide cause hair loss more than Tirzepatide or Semaglutide